tamsulosin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kida, J; Mashimo, H; Matsuya, H; Okada, H; Otsuki, T; Sekido, N; Wakamatsu, D | 1 |
| Chen, S; Feng, X; Li, S; Shi, B; Zhang, Z; Zhu, Y | 1 |
2 other study(ies) available for tamsulosin and Alloxan Diabetes
| Article | Year |
|---|---|
EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Male; Pyridinium Compounds; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Tamsulosin; Thiazoles; Urinary Bladder, Underactive; Urological Agents | 2020 |
Changes in alpha1-adrenoceptor and NGF/proNGF pathway: a possible mechanism in diabetic urethral dysfunction.
Topics: Adaptor Proteins, Vesicular Transport; Adrenergic alpha-1 Receptor Antagonists; Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Nerve Growth Factor; Perfusion; Pressure; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Nerve Growth Factor; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urethra | 2014 |